Urban Edge Properties: Suvoda Enhances Clinical Trial Transportation with Bolt Business Collaboration
- Suvoda partners with Bolt Business to enhance transportation solutions for clinical trial participants in the EU.
- The initiative eliminates out-of-pocket transportation costs, improving patient retention and trial success rates.
- Suvoda's services support over 8,400 sites globally, achieving a 90% satisfaction rate among clinical trial participants.
Enhancing Transportation Solutions for Clinical Trials
Suvoda, a global leader in clinical trial technology, is making strides in addressing one of the significant challenges faced by clinical trial participants: transportation. In a recent collaboration with Bolt Business, a European mobility company, Suvoda aims to improve access to reliable and cost-effective transportation options for individuals involved in clinical studies across the EU. This partnership allows Suvoda specialists to arrange rides for trial participants at no out-of-pocket expense, effectively reducing the financial and logistical burdens that often deter patients from participating in clinical trials. By facilitating easier transportation, Suvoda enhances the overall experience for patients, which is integral for maintaining higher retention rates crucial for the success of clinical studies.
The partnership leverages Greenphire Travel, an integrated service available on the Suvoda platform, thereby streamlining the booking process for clinical trial sites and sponsors. According to Will Wing, Suvoda’s product director, this initiative is pivotal in overcoming travel-related obstacles that patients frequently encounter. The collaboration not only provides a more humane approach to participant logistics but also aligns with Suvoda's commitment to patient retention and trial success. As patients face fewer challenges in transportation, the likelihood of their continued participation in trials increases, ultimately benefiting the research outcomes.
Moreover, the collaboration emphasizes the importance of data privacy and security, ensuring that participants' information is handled with the utmost care. Liam James from Bolt Business underscores the shared commitment between the two companies to dismantle barriers faced by trial participants and offer flexible transport solutions tailored to the diverse EU markets. Suvoda’s transportation services have already made significant strides, supporting over 8,400 sites in more than 2,000 studies across 50 countries, and achieving a remarkable 90% satisfaction rate among global sites. This partnership with Bolt Business stands as a vital advancement in Suvoda's mission to streamline patient journeys, further solidifying their role as a pioneer in enhancing access to clinical trials.
In addition to improving transportation logistics, Suvoda's initiative underscores the growing recognition of the need for comprehensive support for clinical trial participants, particularly those involved in studies for rare and ultra-rare diseases. The integration of personalized assistance through dedicated concierge coordinators ensures that patients receive the attention and care necessary for a positive trial experience.
As Suvoda continues to invest in innovative solutions, their partnership with Bolt Business represents a forward-thinking approach that prioritizes patient access and convenience, setting a new standard for clinical trial logistics in the industry.